• Skip to main content

Hearing Loss Treatment Report

www.HearingLossTreatmentReport.com

DB-OTO

Decibel Therapeutics to Present at the 44th Annual ARO Conference [DB-OTO gene therapy]

February 19, 2021

https://ir.decibeltx.com/news-releases/news-release-details/decibel-therapeutics-present-44th-annual-association-research

Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference

Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Hearing Loss

February 4, 2021

Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Congenital Hearing Loss

Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Hearing Loss

Powered by Urgent Research

Copyright © 2025 Urgent Research